Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

CD46: The 'multitasker' of complement proteins.
Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells.
Neuromyelitis optica.
Chaperone activity of α B-crystallin is responsible for its incorrect assignment as an autoantigen in multiple sclerosis.
A phase II study of laquinimod in Crohn's disease.
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases.
Benefit of additional screening for progressive multifocal leukoencephalopathy in patients with multiple sclerosis taking natalizumab: a decision analysis.
Potassium-Retaining Diuretics: Amiloride
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg
Yield of emergent neuroimaging among children presenting with a first complex febrile seizure.
Monosymptomatic clinically isolated syndrome with sudden sensorineural hearing loss: case report and critical review of the literature.
Disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with daclizumab high-yield process in the SELECT study.
Modulation of Sox10, HIF-1α, Survivin, and YAP by Minocycline in the Treatment of Neurodevelopmental Handicaps following Hypoxic Insult.
A practical review of the neuropathology and neuroimaging of multiple sclerosis.
In vitro Biological Characterization of IFN-β-1a major Glycoforms.
FDA approves Ampyra to improve walking in adults with multiple sclerosis
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Myasthenia gravis and neuromyelitis optica spectrum disorder: A multicenter study of 16 patients.
Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial.
Natural History of Multiple Sclerosis Symptoms
Natalizumab in pediatric multiple sclerosis: results of a cohort of 55 cases.
Astrocytes Underlie Neuroinflammatory Memory Impairment.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Accelerated and enhanced effect of CCR5-transduced bone marrow neural stem cells on autoimmune encephalomyelitis.

Pages